Medical Innovation Exchange

After nearly 20 years, Cyclacel kicks phase 3 leukemia drug back to Daiichi

https://www.fiercebiotech.com/biotech/cylcacel-back-peddles-phase-3-leukemia-drug-kicking-rights-over-daiichi

Leave a Comment

Your email address will not be published. Required fields are marked *

Leave the field below empty!